[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fcuTiUlCo8jyh8n0A9_me4LTU3bFK2woy1fdQABtBl7M":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":49,"rows":56},"Ajou University School of Medicine",[4],171,false,5,3,10280901,4,94,[14,17,20,23,25,27,29,31],{"name":15,"count":16},"Gastric Cancer",8,{"name":18,"count":19},"Intubation;Difficult",7,{"name":21,"count":22},"Drug Usage",6,{"name":24,"count":22},"Intubation",{"name":26,"count":22},"Gallbladder Diseases",{"name":28,"count":8},"Obesity",{"name":30,"count":8},"Trauma",{"name":32,"count":11},"Anesthesia",[34,39,44],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT06964217","Immediate Fracture Risk After Antihypertensive Drug Initiation","2025-07-28","Monotherapy",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT05751603","Effectiveness on Smooth Extubation According to the Administration Time of Sugammadex","2025-10-03","sugammadex",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT06015711","The Effect of Preoperative Maxigesic® on Intraoperative Remifentanil Requirement","2026-08-31","Maxigesic administration",[50,51,52,53,54,55],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[57,105,128,152,170,209,240,262,289,307,332,358,376,405,423,449,475,504,522,540,566,584,609,635,653,681,706,731,760,778,804,822,846,868,894,912,930,957,975,998,1022,1060,1086,1112,1139,1157,1183,1201,1219,1246,1264,1289,1307,1333,1351,1369,1471,1549,1625,1666,1696,1718,1740,1774,1796,1833,1855,1873,1896,1924,1942,1967,1985,2003,2030,2054,2080,2107,2125,2143,2161,2190,2208,2235,2261,2279,2306,2324,2349,2367,2385,2403,2427,2445,2471,2489],{"intervention":58,"totalTrials":9,"cells":59},"Sugammadex",{"EARLY_PHASE1":60,"PHASE1":63,"PHASE2":65,"PHASE3":67,"PHASE4":69,"NA":71},{"trials":61,"activeCount":62},[],0,{"trials":64,"activeCount":62},[],{"trials":66,"activeCount":62},[],{"trials":68,"activeCount":62},[],{"trials":70,"activeCount":62},[],{"trials":72,"activeCount":104,"soonestReadout":42},[73,82,94],{"nctId":40,"briefTitle":41,"status":74,"phases":75,"primaryCompletion":42,"completion":42,"start":76,"enrollment":77,"conditions":78,"interventions":81},"NOT_YET_RECRUITING",[55],"2024-10-03",66,[58,79,80],"Extubation","Smooth Emergence",[43],{"nctId":83,"briefTitle":84,"status":85,"phases":86,"primaryCompletion":87,"completion":88,"start":89,"enrollment":90,"conditions":91,"interventions":93},"NCT03619759","The Effect of Sugammadex on the Outcome After Colorectal Cancer Surgery","COMPLETED",[],"2018-08-31","2018-09-01","2018-03-22",585,[92],"Outcome, Fatal",[58],{"nctId":95,"briefTitle":96,"status":85,"phases":97,"primaryCompletion":98,"completion":98,"start":99,"enrollment":100,"conditions":101,"interventions":102},"NCT04205097","Deep vs Moderate Neuromuscular Blocks on Remifentanil for Laparoscopic Gastrectomy",[55],"2020-12-02","2019-12-23",120,[15],[103,58],"Neostigmine + glycopyrate",1,{"intervention":48,"totalTrials":104,"cells":106},{"EARLY_PHASE1":107,"PHASE1":109,"PHASE2":111,"PHASE3":113,"PHASE4":115,"NA":117},{"trials":108,"activeCount":62},[],{"trials":110,"activeCount":62},[],{"trials":112,"activeCount":62},[],{"trials":114,"activeCount":62},[],{"trials":116,"activeCount":62},[],{"trials":118,"activeCount":104,"soonestReadout":47},[119],{"nctId":45,"briefTitle":46,"status":120,"phases":121,"primaryCompletion":47,"completion":122,"start":123,"enrollment":124,"conditions":125,"interventions":127},"RECRUITING",[55],"2026-12-31","2023-08-30",96,[126],"Opioid Use",[48],{"intervention":38,"totalTrials":104,"cells":129},{"EARLY_PHASE1":130,"PHASE1":132,"PHASE2":134,"PHASE3":136,"PHASE4":138,"NA":140},{"trials":131,"activeCount":62},[],{"trials":133,"activeCount":62},[],{"trials":135,"activeCount":62},[],{"trials":137,"activeCount":62},[],{"trials":139,"activeCount":62},[],{"trials":141,"activeCount":104,"soonestReadout":37},[142],{"nctId":35,"briefTitle":36,"status":74,"phases":143,"primaryCompletion":37,"completion":144,"start":145,"enrollment":146,"conditions":147,"interventions":150},[],"2025-07-31","2025-06-01",10000000,[148,149],"Hypertension","Fracture",[38,151],"Combination therapy",{"intervention":151,"totalTrials":104,"cells":153},{"EARLY_PHASE1":154,"PHASE1":156,"PHASE2":158,"PHASE3":160,"PHASE4":162,"NA":164},{"trials":155,"activeCount":62},[],{"trials":157,"activeCount":62},[],{"trials":159,"activeCount":62},[],{"trials":161,"activeCount":62},[],{"trials":163,"activeCount":62},[],{"trials":165,"activeCount":104,"soonestReadout":37},[166],{"nctId":35,"briefTitle":36,"status":74,"phases":167,"primaryCompletion":37,"completion":144,"start":145,"enrollment":146,"conditions":168,"interventions":169},[],[148,149],[38,151],{"intervention":171,"totalTrials":172,"cells":173},"rocuronium",2,{"EARLY_PHASE1":174,"PHASE1":176,"PHASE2":178,"PHASE3":180,"PHASE4":182,"NA":207},{"trials":175,"activeCount":62},[],{"trials":177,"activeCount":62},[],{"trials":179,"activeCount":62},[],{"trials":181,"activeCount":62},[],{"trials":183,"activeCount":62},[184,194],{"nctId":185,"briefTitle":186,"status":85,"phases":187,"primaryCompletion":188,"completion":188,"start":189,"enrollment":190,"conditions":191,"interventions":193},"NCT02642367","Stylet Use for McGrath Videolaryngoscope",[54],"2016-05","2016-01",140,[192],"Orotracheal Intubation",[171],{"nctId":195,"briefTitle":196,"status":197,"phases":198,"primaryCompletion":188,"completion":188,"start":189,"enrollment":199,"conditions":200,"interventions":202},"NCT02646709","The Effect of Different Dose of Ketamine With Low Dose Rocuronium in Children","UNKNOWN",[54],60,[201],"Inguinal Hernia",[203,204,205,206],"Rocuronium","ketamine 1","ketamine 1.5","ketamine 2",{"trials":208,"activeCount":62},[],{"intervention":204,"totalTrials":172,"cells":210},{"EARLY_PHASE1":211,"PHASE1":213,"PHASE2":215,"PHASE3":217,"PHASE4":219,"NA":238},{"trials":212,"activeCount":62},[],{"trials":214,"activeCount":62},[],{"trials":216,"activeCount":62},[],{"trials":218,"activeCount":62},[],{"trials":220,"activeCount":62},[221,225],{"nctId":195,"briefTitle":196,"status":197,"phases":222,"primaryCompletion":188,"completion":188,"start":189,"enrollment":199,"conditions":223,"interventions":224},[54],[201],[203,204,205,206],{"nctId":226,"briefTitle":227,"status":85,"phases":228,"primaryCompletion":229,"completion":229,"start":230,"enrollment":231,"conditions":232,"interventions":234},"NCT02655380","Remifentanil Requirement for Acceptable Intubating Condition",[54],"2018-04-16","2017-06-19",51,[233],"Intubating Condition",[235,236,237],"Ketamine 1","Ketamine 2","Remifentanil",{"trials":239,"activeCount":62},[],{"intervention":206,"totalTrials":172,"cells":241},{"EARLY_PHASE1":242,"PHASE1":244,"PHASE2":246,"PHASE3":248,"PHASE4":250,"NA":260},{"trials":243,"activeCount":62},[],{"trials":245,"activeCount":62},[],{"trials":247,"activeCount":62},[],{"trials":249,"activeCount":62},[],{"trials":251,"activeCount":62},[252,256],{"nctId":195,"briefTitle":196,"status":197,"phases":253,"primaryCompletion":188,"completion":188,"start":189,"enrollment":199,"conditions":254,"interventions":255},[54],[201],[203,204,205,206],{"nctId":226,"briefTitle":227,"status":85,"phases":257,"primaryCompletion":229,"completion":229,"start":230,"enrollment":231,"conditions":258,"interventions":259},[54],[233],[235,236,237],{"trials":261,"activeCount":62},[],{"intervention":263,"totalTrials":104,"cells":264},"3 months DAPT",{"EARLY_PHASE1":265,"PHASE1":267,"PHASE2":269,"PHASE3":271,"PHASE4":273,"NA":287},{"trials":266,"activeCount":62},[],{"trials":268,"activeCount":62},[],{"trials":270,"activeCount":62},[],{"trials":272,"activeCount":62},[],{"trials":274,"activeCount":62},[275],{"nctId":276,"briefTitle":277,"status":197,"phases":278,"primaryCompletion":279,"completion":280,"start":281,"enrollment":282,"conditions":283,"interventions":285},"NCT02609698","ISAR-DAPT (A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial)",[54],"2018-12","2019-06","2015-08",906,[284],"Stable Angina, Unstable Angina, Silent Coronary Ischemia, Coronary Artery Disease",[263,286],"6 months DAPT",{"trials":288,"activeCount":62},[],{"intervention":286,"totalTrials":104,"cells":290},{"EARLY_PHASE1":291,"PHASE1":293,"PHASE2":295,"PHASE3":297,"PHASE4":299,"NA":305},{"trials":292,"activeCount":62},[],{"trials":294,"activeCount":62},[],{"trials":296,"activeCount":62},[],{"trials":298,"activeCount":62},[],{"trials":300,"activeCount":62},[301],{"nctId":276,"briefTitle":277,"status":197,"phases":302,"primaryCompletion":279,"completion":280,"start":281,"enrollment":282,"conditions":303,"interventions":304},[54],[284],[263,286],{"trials":306,"activeCount":62},[],{"intervention":308,"totalTrials":104,"cells":309},"advagrf",{"EARLY_PHASE1":310,"PHASE1":312,"PHASE2":314,"PHASE3":316,"PHASE4":318,"NA":330},{"trials":311,"activeCount":62},[],{"trials":313,"activeCount":62},[],{"trials":315,"activeCount":62},[],{"trials":317,"activeCount":62},[],{"trials":319,"activeCount":62},[320],{"nctId":321,"briefTitle":322,"status":85,"phases":323,"primaryCompletion":324,"completion":324,"start":325,"enrollment":326,"conditions":327,"interventions":329},"NCT01964014","Once-a-day Immunosuppression(CISECON_a_day)",[54],"2015-10","2013-10",160,[328],"Chronic Renal Disease",[308],{"trials":331,"activeCount":62},[],{"intervention":333,"totalTrials":104,"cells":334},"Fentanyl",{"EARLY_PHASE1":335,"PHASE1":337,"PHASE2":339,"PHASE3":341,"PHASE4":343,"NA":356},{"trials":336,"activeCount":62},[],{"trials":338,"activeCount":62},[],{"trials":340,"activeCount":62},[],{"trials":342,"activeCount":62},[],{"trials":344,"activeCount":62},[345],{"nctId":346,"briefTitle":347,"status":85,"phases":348,"primaryCompletion":349,"completion":349,"start":350,"enrollment":351,"conditions":352,"interventions":354},"NCT02651311","Ultrasound Guided Intermediate Cervical Plexus Block for Congenital Muscular Torticollis",[54],"2016-12-15","2016-01-16",32,[353],"Congenital Muscular Torticollis",[333,355],"Ibuprofen",{"trials":357,"activeCount":62},[],{"intervention":355,"totalTrials":104,"cells":359},{"EARLY_PHASE1":360,"PHASE1":362,"PHASE2":364,"PHASE3":366,"PHASE4":368,"NA":374},{"trials":361,"activeCount":62},[],{"trials":363,"activeCount":62},[],{"trials":365,"activeCount":62},[],{"trials":367,"activeCount":62},[],{"trials":369,"activeCount":62},[370],{"nctId":346,"briefTitle":347,"status":85,"phases":371,"primaryCompletion":349,"completion":349,"start":350,"enrollment":351,"conditions":372,"interventions":373},[54],[353],[333,355],{"trials":375,"activeCount":62},[],{"intervention":377,"totalTrials":104,"cells":378},"Palonosetron",{"EARLY_PHASE1":379,"PHASE1":381,"PHASE2":383,"PHASE3":385,"PHASE4":387,"NA":403},{"trials":380,"activeCount":62},[],{"trials":382,"activeCount":62},[],{"trials":384,"activeCount":62},[],{"trials":386,"activeCount":62},[],{"trials":388,"activeCount":62},[389],{"nctId":390,"briefTitle":391,"status":85,"phases":392,"primaryCompletion":393,"completion":393,"start":394,"enrollment":395,"conditions":396,"interventions":398},"NCT02809378","The Effects of Anesthetic Techniques and Palonosetron Administration on the Incidence of PONV",[54],"2017-04-20","2016-06",150,[397,377,32],"PONV",[377,399,400,401,402],"sevoflurane","remifentanil","pentothal sodium","propofol",{"trials":404,"activeCount":62},[],{"intervention":401,"totalTrials":104,"cells":406},{"EARLY_PHASE1":407,"PHASE1":409,"PHASE2":411,"PHASE3":413,"PHASE4":415,"NA":421},{"trials":408,"activeCount":62},[],{"trials":410,"activeCount":62},[],{"trials":412,"activeCount":62},[],{"trials":414,"activeCount":62},[],{"trials":416,"activeCount":62},[417],{"nctId":390,"briefTitle":391,"status":85,"phases":418,"primaryCompletion":393,"completion":393,"start":394,"enrollment":395,"conditions":419,"interventions":420},[54],[397,377,32],[377,399,400,401,402],{"trials":422,"activeCount":62},[],{"intervention":424,"totalTrials":104,"cells":425},"Tacrolimus",{"EARLY_PHASE1":426,"PHASE1":428,"PHASE2":430,"PHASE3":432,"PHASE4":434,"NA":447},{"trials":427,"activeCount":62},[],{"trials":429,"activeCount":62},[],{"trials":431,"activeCount":62},[],{"trials":433,"activeCount":62},[],{"trials":435,"activeCount":62},[436],{"nctId":437,"briefTitle":438,"status":85,"phases":439,"primaryCompletion":440,"completion":441,"start":442,"enrollment":443,"conditions":444,"interventions":446},"NCT03968588","Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal Transplantation",[54],"2016-11-11","2017-06-14","2014-07-29",108,[445],"Disorder Related to Renal Transplantation",[424,424],{"trials":448,"activeCount":62},[],{"intervention":450,"totalTrials":104,"cells":451},"LAIS®",{"EARLY_PHASE1":452,"PHASE1":454,"PHASE2":456,"PHASE3":458,"PHASE4":460,"NA":473},{"trials":453,"activeCount":62},[],{"trials":455,"activeCount":62},[],{"trials":457,"activeCount":62},[],{"trials":459,"activeCount":62},[],{"trials":461,"activeCount":62},[462],{"nctId":463,"briefTitle":464,"status":197,"phases":465,"primaryCompletion":466,"completion":467,"start":468,"enrollment":469,"conditions":470,"interventions":472},"NCT02277483","Efficacy and Safety of LAIS® Mites Sublingual Tablets",[54],"2016-07","2016-12","2014-10",45,[471],"Allergic Conditions",[450],{"trials":474,"activeCount":62},[],{"intervention":476,"totalTrials":104,"cells":477},"Fimasartan",{"EARLY_PHASE1":478,"PHASE1":480,"PHASE2":482,"PHASE3":484,"PHASE4":486,"NA":502},{"trials":479,"activeCount":62},[],{"trials":481,"activeCount":62},[],{"trials":483,"activeCount":62},[],{"trials":485,"activeCount":62},[],{"trials":487,"activeCount":62},[488],{"nctId":489,"briefTitle":490,"status":197,"phases":491,"primaryCompletion":492,"completion":493,"start":494,"enrollment":495,"conditions":496,"interventions":499},"NCT02403349","Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol",[54],"2015-05","2015-09","2012-05",105,[497,498],"Blood Pressure","Ischemic Stroke",[476,500,501],"Valsartan","Atenolol",{"trials":503,"activeCount":62},[],{"intervention":500,"totalTrials":104,"cells":505},{"EARLY_PHASE1":506,"PHASE1":508,"PHASE2":510,"PHASE3":512,"PHASE4":514,"NA":520},{"trials":507,"activeCount":62},[],{"trials":509,"activeCount":62},[],{"trials":511,"activeCount":62},[],{"trials":513,"activeCount":62},[],{"trials":515,"activeCount":62},[516],{"nctId":489,"briefTitle":490,"status":197,"phases":517,"primaryCompletion":492,"completion":493,"start":494,"enrollment":495,"conditions":518,"interventions":519},[54],[497,498],[476,500,501],{"trials":521,"activeCount":62},[],{"intervention":501,"totalTrials":104,"cells":523},{"EARLY_PHASE1":524,"PHASE1":526,"PHASE2":528,"PHASE3":530,"PHASE4":532,"NA":538},{"trials":525,"activeCount":62},[],{"trials":527,"activeCount":62},[],{"trials":529,"activeCount":62},[],{"trials":531,"activeCount":62},[],{"trials":533,"activeCount":62},[534],{"nctId":489,"briefTitle":490,"status":197,"phases":535,"primaryCompletion":492,"completion":493,"start":494,"enrollment":495,"conditions":536,"interventions":537},[54],[497,498],[476,500,501],{"trials":539,"activeCount":62},[],{"intervention":541,"totalTrials":104,"cells":542},"generic clopidogrel",{"EARLY_PHASE1":543,"PHASE1":545,"PHASE2":547,"PHASE3":549,"PHASE4":551,"NA":564},{"trials":544,"activeCount":62},[],{"trials":546,"activeCount":62},[],{"trials":548,"activeCount":62},[],{"trials":550,"activeCount":62},[],{"trials":552,"activeCount":62},[553],{"nctId":554,"briefTitle":555,"status":85,"phases":556,"primaryCompletion":557,"completion":557,"start":558,"enrollment":559,"conditions":560,"interventions":562},"NCT02060786","Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)",[54],"2013-06","2010-10",90,[561],"Acute Coronary Syndrome",[541,563],"original clopidogrel",{"trials":565,"activeCount":62},[],{"intervention":563,"totalTrials":104,"cells":567},{"EARLY_PHASE1":568,"PHASE1":570,"PHASE2":572,"PHASE3":574,"PHASE4":576,"NA":582},{"trials":569,"activeCount":62},[],{"trials":571,"activeCount":62},[],{"trials":573,"activeCount":62},[],{"trials":575,"activeCount":62},[],{"trials":577,"activeCount":62},[578],{"nctId":554,"briefTitle":555,"status":85,"phases":579,"primaryCompletion":557,"completion":557,"start":558,"enrollment":559,"conditions":580,"interventions":581},[54],[561],[541,563],{"trials":583,"activeCount":62},[],{"intervention":585,"totalTrials":104,"cells":586},"Helicobacter pylori eradication",{"EARLY_PHASE1":587,"PHASE1":589,"PHASE2":591,"PHASE3":593,"PHASE4":595,"NA":607},{"trials":588,"activeCount":62},[],{"trials":590,"activeCount":62},[],{"trials":592,"activeCount":62},[],{"trials":594,"activeCount":62},[],{"trials":596,"activeCount":62},[597],{"nctId":598,"briefTitle":599,"status":197,"phases":600,"primaryCompletion":601,"start":602,"enrollment":603,"conditions":604,"interventions":606},"NCT01938534","Prospective Study : Helicobacter Pylori Eradication Therapy in Accordance With Past Antibiotics Use",[54],"2014-12","2013-09",440,[605],"Helicobacter Eradication",[585],{"trials":608,"activeCount":62},[],{"intervention":610,"totalTrials":104,"cells":611},"Nateglinide",{"EARLY_PHASE1":612,"PHASE1":614,"PHASE2":616,"PHASE3":618,"PHASE4":620,"NA":633},{"trials":613,"activeCount":62},[],{"trials":615,"activeCount":62},[],{"trials":617,"activeCount":62},[],{"trials":619,"activeCount":62},[],{"trials":621,"activeCount":62},[622],{"nctId":623,"briefTitle":624,"status":85,"phases":625,"primaryCompletion":626,"completion":626,"start":627,"enrollment":628,"conditions":629,"interventions":631},"NCT00858013","Study of the Durability of Glycemic Control With Nateglinide",[54],"2014-06-25","2009-04-24",88,[630],"Type 2 Diabetes Mellitus",[610,632],"Glimepiride",{"trials":634,"activeCount":62},[],{"intervention":632,"totalTrials":104,"cells":636},{"EARLY_PHASE1":637,"PHASE1":639,"PHASE2":641,"PHASE3":643,"PHASE4":645,"NA":651},{"trials":638,"activeCount":62},[],{"trials":640,"activeCount":62},[],{"trials":642,"activeCount":62},[],{"trials":644,"activeCount":62},[],{"trials":646,"activeCount":62},[647],{"nctId":623,"briefTitle":624,"status":85,"phases":648,"primaryCompletion":626,"completion":626,"start":627,"enrollment":628,"conditions":649,"interventions":650},[54],[630],[610,632],{"trials":652,"activeCount":62},[],{"intervention":654,"totalTrials":104,"cells":655},"Pregabalin 25 MG",{"EARLY_PHASE1":656,"PHASE1":658,"PHASE2":660,"PHASE3":662,"PHASE4":664,"NA":679},{"trials":657,"activeCount":62},[],{"trials":659,"activeCount":62},[],{"trials":661,"activeCount":62},[],{"trials":663,"activeCount":62},[],{"trials":665,"activeCount":62},[666],{"nctId":667,"briefTitle":668,"status":197,"phases":669,"primaryCompletion":670,"completion":670,"start":671,"enrollment":672,"conditions":673,"interventions":678},"NCT05478382","Pregabalin is an Effective Treatment for Acute Postoperative Pain Following Spinal Surgery Without Major Side Effects",[54],"2025-12-31","2022-10",132,[674,675,676,677],"Postoperative Pain","Pregabalin","Spine Surgery","Adverse Reaction to Pregabalin",[654],{"trials":680,"activeCount":62},[],{"intervention":682,"totalTrials":104,"cells":683},"Pentoxifylline",{"EARLY_PHASE1":684,"PHASE1":686,"PHASE2":688,"PHASE3":690,"PHASE4":692,"NA":704},{"trials":685,"activeCount":62},[],{"trials":687,"activeCount":62},[],{"trials":689,"activeCount":62},[],{"trials":691,"activeCount":62},[],{"trials":693,"activeCount":62},[694],{"nctId":695,"briefTitle":696,"status":85,"phases":697,"primaryCompletion":698,"completion":698,"start":699,"enrollment":700,"conditions":701,"interventions":703},"NCT01382303","Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients",[54],"2013-12-20","2010-10-25",174,[702],"Type 2 Diabetes",[682],{"trials":705,"activeCount":62},[],{"intervention":707,"totalTrials":104,"cells":708},"Prednisolone",{"EARLY_PHASE1":709,"PHASE1":711,"PHASE2":713,"PHASE3":715,"PHASE4":717,"NA":729},{"trials":710,"activeCount":62},[],{"trials":712,"activeCount":62},[],{"trials":714,"activeCount":62},[],{"trials":716,"activeCount":62},[],{"trials":718,"activeCount":62},[719],{"nctId":720,"briefTitle":721,"status":197,"phases":722,"primaryCompletion":723,"completion":724,"start":725,"enrollment":726,"conditions":727,"interventions":728},"NCT01550445","Steroid Withdrawal Immunosuppression After Renal Transplantation",[54],"2009-10","2012-07","2008-05",30,[445],[707],{"trials":730,"activeCount":62},[],{"intervention":732,"totalTrials":104,"cells":733},"atropine 0.5mg",{"EARLY_PHASE1":734,"PHASE1":736,"PHASE2":738,"PHASE3":740,"PHASE4":742,"NA":758},{"trials":735,"activeCount":62},[],{"trials":737,"activeCount":62},[],{"trials":739,"activeCount":62},[],{"trials":741,"activeCount":62},[],{"trials":743,"activeCount":62},[744],{"nctId":745,"briefTitle":746,"status":85,"phases":747,"primaryCompletion":748,"completion":748,"start":749,"enrollment":750,"conditions":751,"interventions":755},"NCT03984526","Atropine or Ephedrine Pretreatment for Preventing Bradycardia in Elderly Patients",[54],"2020-09-15","2019-06-25",102,[752,753,754],"Anesthesia, Spinal","Dexmedetomidine","Bradycardia",[756,732,757],"normal saline","ephedrine 8mg",{"trials":759,"activeCount":62},[],{"intervention":757,"totalTrials":104,"cells":761},{"EARLY_PHASE1":762,"PHASE1":764,"PHASE2":766,"PHASE3":768,"PHASE4":770,"NA":776},{"trials":763,"activeCount":62},[],{"trials":765,"activeCount":62},[],{"trials":767,"activeCount":62},[],{"trials":769,"activeCount":62},[],{"trials":771,"activeCount":62},[772],{"nctId":745,"briefTitle":746,"status":85,"phases":773,"primaryCompletion":748,"completion":748,"start":749,"enrollment":750,"conditions":774,"interventions":775},[54],[752,753,754],[756,732,757],{"trials":777,"activeCount":62},[],{"intervention":779,"totalTrials":104,"cells":780},"Cilostazol 100mg",{"EARLY_PHASE1":781,"PHASE1":783,"PHASE2":785,"PHASE3":787,"PHASE4":789,"NA":802},{"trials":782,"activeCount":62},[],{"trials":784,"activeCount":62},[],{"trials":786,"activeCount":62},[],{"trials":788,"activeCount":62},[],{"trials":790,"activeCount":62},[791],{"nctId":792,"briefTitle":793,"status":85,"phases":794,"primaryCompletion":795,"completion":795,"start":796,"enrollment":797,"conditions":798,"interventions":800},"NCT03116269","The Effect of Cilostazol Compared to Aspirin on Endothelial Function in Acute Cerebral Ischemia Patients",[54],"2014-10-31","2012-03-01",80,[498,799],"Endothelial Dysfunction",[779,801],"Aspirin",{"trials":803,"activeCount":62},[],{"intervention":801,"totalTrials":104,"cells":805},{"EARLY_PHASE1":806,"PHASE1":808,"PHASE2":810,"PHASE3":812,"PHASE4":814,"NA":820},{"trials":807,"activeCount":62},[],{"trials":809,"activeCount":62},[],{"trials":811,"activeCount":62},[],{"trials":813,"activeCount":62},[],{"trials":815,"activeCount":62},[816],{"nctId":792,"briefTitle":793,"status":85,"phases":817,"primaryCompletion":795,"completion":795,"start":796,"enrollment":797,"conditions":818,"interventions":819},[54],[498,799],[779,801],{"trials":821,"activeCount":62},[],{"intervention":823,"totalTrials":104,"cells":824},"Remifentanil titration",{"EARLY_PHASE1":825,"PHASE1":827,"PHASE2":829,"PHASE3":831,"PHASE4":833,"NA":844},{"trials":826,"activeCount":62},[],{"trials":828,"activeCount":62},[],{"trials":830,"activeCount":62},[],{"trials":832,"activeCount":62},[],{"trials":834,"activeCount":62},[835],{"nctId":836,"briefTitle":837,"status":85,"phases":838,"primaryCompletion":281,"completion":281,"start":839,"enrollment":840,"conditions":841,"interventions":843},"NCT02528825","Effect-site Concentration of Remifentanil for Smooth Removal of the Double-lumen Endotracheal Tube",[54],"2014-11",25,[842],"Remifentanil Concentration for Smooth Emergence",[823],{"trials":845,"activeCount":62},[],{"intervention":847,"totalTrials":104,"cells":848},"Desflurane",{"EARLY_PHASE1":849,"PHASE1":851,"PHASE2":853,"PHASE3":855,"PHASE4":857,"NA":866},{"trials":850,"activeCount":62},[],{"trials":852,"activeCount":62},[],{"trials":854,"activeCount":62},[],{"trials":856,"activeCount":62},[],{"trials":858,"activeCount":62},[859],{"nctId":860,"briefTitle":861,"status":85,"phases":862,"primaryCompletion":492,"completion":492,"start":601,"enrollment":863,"conditions":864,"interventions":865},"NCT02379715","Effect-site Concentration of Remifentanil for Smooth Induction With Desflurane",[54],26,[32],[237,847],{"trials":867,"activeCount":62},[],{"intervention":869,"totalTrials":104,"cells":870},"Combination of low ICS and montelukast",{"EARLY_PHASE1":871,"PHASE1":873,"PHASE2":875,"PHASE3":877,"PHASE4":879,"NA":892},{"trials":872,"activeCount":62},[],{"trials":874,"activeCount":62},[],{"trials":876,"activeCount":62},[],{"trials":878,"activeCount":62},[],{"trials":880,"activeCount":62},[881],{"nctId":882,"briefTitle":883,"status":85,"phases":884,"primaryCompletion":885,"completion":885,"start":886,"enrollment":190,"conditions":887,"interventions":890},"NCT01147510","Asthma Control in Elderly Patients With Montelukast",[54],"2012-09","2010-07",[888,889],"Persistent Asthma","Elderly",[869,891],"Monotherapy of medium dose ICS",{"trials":893,"activeCount":62},[],{"intervention":891,"totalTrials":104,"cells":895},{"EARLY_PHASE1":896,"PHASE1":898,"PHASE2":900,"PHASE3":902,"PHASE4":904,"NA":910},{"trials":897,"activeCount":62},[],{"trials":899,"activeCount":62},[],{"trials":901,"activeCount":62},[],{"trials":903,"activeCount":62},[],{"trials":905,"activeCount":62},[906],{"nctId":882,"briefTitle":883,"status":85,"phases":907,"primaryCompletion":885,"completion":885,"start":886,"enrollment":190,"conditions":908,"interventions":909},[54],[888,889],[869,891],{"trials":911,"activeCount":62},[],{"intervention":205,"totalTrials":104,"cells":913},{"EARLY_PHASE1":914,"PHASE1":916,"PHASE2":918,"PHASE3":920,"PHASE4":922,"NA":928},{"trials":915,"activeCount":62},[],{"trials":917,"activeCount":62},[],{"trials":919,"activeCount":62},[],{"trials":921,"activeCount":62},[],{"trials":923,"activeCount":62},[924],{"nctId":195,"briefTitle":196,"status":197,"phases":925,"primaryCompletion":188,"completion":188,"start":189,"enrollment":199,"conditions":926,"interventions":927},[54],[201],[203,204,205,206],{"trials":929,"activeCount":62},[],{"intervention":931,"totalTrials":104,"cells":932},"Phloroglucin",{"EARLY_PHASE1":933,"PHASE1":935,"PHASE2":937,"PHASE3":939,"PHASE4":941,"NA":955},{"trials":934,"activeCount":62},[],{"trials":936,"activeCount":62},[],{"trials":938,"activeCount":62},[],{"trials":940,"activeCount":62},[],{"trials":942,"activeCount":62},[943],{"nctId":944,"briefTitle":945,"status":197,"phases":946,"primaryCompletion":947,"completion":948,"start":949,"enrollment":950,"conditions":951,"interventions":953},"NCT01842932","Usefulness Of Flospan As A Premedication For Colonoscopy",[54],"2013-12","2015-12","2009-12",260,[952],"Colonoscopy",[931,954],"Cimetropium bromide",{"trials":956,"activeCount":62},[],{"intervention":954,"totalTrials":104,"cells":958},{"EARLY_PHASE1":959,"PHASE1":961,"PHASE2":963,"PHASE3":965,"PHASE4":967,"NA":973},{"trials":960,"activeCount":62},[],{"trials":962,"activeCount":62},[],{"trials":964,"activeCount":62},[],{"trials":966,"activeCount":62},[],{"trials":968,"activeCount":62},[969],{"nctId":944,"briefTitle":945,"status":197,"phases":970,"primaryCompletion":947,"completion":948,"start":949,"enrollment":950,"conditions":971,"interventions":972},[54],[952],[931,954],{"trials":974,"activeCount":62},[],{"intervention":976,"totalTrials":104,"cells":977},"Immune Globulin",{"EARLY_PHASE1":978,"PHASE1":980,"PHASE2":982,"PHASE3":984,"PHASE4":994,"NA":996},{"trials":979,"activeCount":62},[],{"trials":981,"activeCount":62},[],{"trials":983,"activeCount":62},[],{"trials":985,"activeCount":62},[986],{"nctId":987,"briefTitle":988,"status":197,"phases":989,"primaryCompletion":990,"completion":990,"start":947,"enrollment":726,"conditions":991,"interventions":993},"NCT01992328","IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency",[53],"2017-01",[992],"Asthma",[976],{"trials":995,"activeCount":62},[],{"trials":997,"activeCount":62},[],{"intervention":999,"totalTrials":104,"cells":1000},"Autologous immunoglobulin",{"EARLY_PHASE1":1001,"PHASE1":1003,"PHASE2":1005,"PHASE3":1007,"PHASE4":1018,"NA":1020},{"trials":1002,"activeCount":62},[],{"trials":1004,"activeCount":62},[],{"trials":1006,"activeCount":62},[],{"trials":1008,"activeCount":62},[1009],{"nctId":1010,"briefTitle":1011,"status":85,"phases":1012,"primaryCompletion":1013,"completion":1013,"start":1014,"enrollment":231,"conditions":1015,"interventions":1017},"NCT02835170","Study of Autologous Total Immunoglobulin G Therapy for Atopic Dermatitis",[52,53],"2017-03-27","2015-04-02",[1016],"Dermatitis, Atopic",[999],{"trials":1019,"activeCount":62},[],{"trials":1021,"activeCount":62},[],{"intervention":1023,"totalTrials":172,"cells":1024},"erythropoietin",{"EARLY_PHASE1":1025,"PHASE1":1027,"PHASE2":1029,"PHASE3":1054,"PHASE4":1056,"NA":1058},{"trials":1026,"activeCount":62},[],{"trials":1028,"activeCount":62},[],{"trials":1030,"activeCount":62},[1031,1042],{"nctId":1032,"briefTitle":1033,"status":85,"phases":1034,"primaryCompletion":1035,"completion":1036,"start":1037,"enrollment":1038,"conditions":1039,"interventions":1041},"NCT02603406","Neovascularization Induced by Mechanical Barrier disrUption and Systemic Erythropoietin in Patients With Cerebral Perfusion Deficits",[52],"2019-07-16","2019-12-31","2016-07-15",44,[1040,498],"Angiogenesis",[1023],{"nctId":1043,"briefTitle":1044,"status":85,"phases":1045,"primaryCompletion":1046,"completion":1046,"start":1047,"enrollment":1048,"conditions":1049,"interventions":1053},"NCT03162588","Multiple Burrhole Therapy With Erythropoietin for Unstable Moyamoya",[51,52],"2016-09-30","2010-05-01",37,[1050,498,1051,1052,1040],"Ischemic Attack","Moyamoya Disease","Burr Hole",[1023],{"trials":1055,"activeCount":62},[],{"trials":1057,"activeCount":62},[],{"trials":1059,"activeCount":62},[],{"intervention":1061,"totalTrials":104,"cells":1062},"sulodexide",{"EARLY_PHASE1":1063,"PHASE1":1065,"PHASE2":1067,"PHASE3":1080,"PHASE4":1082,"NA":1084},{"trials":1064,"activeCount":62},[],{"trials":1066,"activeCount":62},[],{"trials":1068,"activeCount":62},[1069],{"nctId":1070,"briefTitle":1071,"status":85,"phases":1072,"primaryCompletion":1073,"completion":1074,"start":1075,"enrollment":1076,"conditions":1077,"interventions":1079},"NCT01295775","Diabetic Retinopathy Sulodexide Study",[52],"2011-04","2011-05","2009-02",127,[1078],"Diabetic Retinopathy",[1061],{"trials":1081,"activeCount":62},[],{"trials":1083,"activeCount":62},[],{"trials":1085,"activeCount":62},[],{"intervention":1087,"totalTrials":104,"cells":1088},"Montelukast",{"EARLY_PHASE1":1089,"PHASE1":1091,"PHASE2":1093,"PHASE3":1106,"PHASE4":1108,"NA":1110},{"trials":1090,"activeCount":62},[],{"trials":1092,"activeCount":62},[],{"trials":1094,"activeCount":62},[1095],{"nctId":1096,"briefTitle":1097,"status":85,"phases":1098,"primaryCompletion":325,"completion":325,"start":1099,"enrollment":1100,"conditions":1101,"interventions":1105},"NCT01717625","The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia",[52],"2011-11",72,[1102,1103,1104],"Premature Birth","Infant, Very Low Birth Weight","Bronchopulmonary Dysplasia",[1087],{"trials":1107,"activeCount":62},[],{"trials":1109,"activeCount":62},[],{"trials":1111,"activeCount":62},[],{"intervention":1113,"totalTrials":104,"cells":1114},"Part A) Healthy subjects",{"EARLY_PHASE1":1115,"PHASE1":1117,"PHASE2":1119,"PHASE3":1133,"PHASE4":1135,"NA":1137},{"trials":1116,"activeCount":62},[],{"trials":1118,"activeCount":62},[],{"trials":1120,"activeCount":62},[1121],{"nctId":1122,"briefTitle":1123,"status":85,"phases":1124,"primaryCompletion":1125,"completion":1126,"start":1127,"enrollment":1128,"conditions":1129,"interventions":1131},"NCT03695757","Development of a New Immunotherapy Using Intramuscular Administration of Autologous Total IgG",[51,52],"2021-01-26","2021-03-24","2018-11-06",24,[1130],"Immunotherapy",[1113,1132],"Part B) Advanced solid tumor",{"trials":1134,"activeCount":62},[],{"trials":1136,"activeCount":62},[],{"trials":1138,"activeCount":62},[],{"intervention":1132,"totalTrials":104,"cells":1140},{"EARLY_PHASE1":1141,"PHASE1":1143,"PHASE2":1145,"PHASE3":1151,"PHASE4":1153,"NA":1155},{"trials":1142,"activeCount":62},[],{"trials":1144,"activeCount":62},[],{"trials":1146,"activeCount":62},[1147],{"nctId":1122,"briefTitle":1123,"status":85,"phases":1148,"primaryCompletion":1125,"completion":1126,"start":1127,"enrollment":1128,"conditions":1149,"interventions":1150},[51,52],[1130],[1113,1132],{"trials":1152,"activeCount":62},[],{"trials":1154,"activeCount":62},[],{"trials":1156,"activeCount":62},[],{"intervention":1158,"totalTrials":104,"cells":1159},"Sarpogrelate pretreatment",{"EARLY_PHASE1":1160,"PHASE1":1162,"PHASE2":1175,"PHASE3":1177,"PHASE4":1179,"NA":1181},{"trials":1161,"activeCount":62},[],{"trials":1163,"activeCount":62},[1164],{"nctId":1165,"briefTitle":1166,"status":85,"phases":1167,"primaryCompletion":1168,"completion":601,"start":947,"enrollment":1169,"conditions":1170,"interventions":1172},"NCT02097511","Sarpogrelate Drug Interaction",[51],"2014-01",9,[148,1171],"Peripheral Artery Disease",[1158,1173,1174],"Sarpogrelate","Metoprolol",{"trials":1176,"activeCount":62},[],{"trials":1178,"activeCount":62},[],{"trials":1180,"activeCount":62},[],{"trials":1182,"activeCount":62},[],{"intervention":1173,"totalTrials":104,"cells":1184},{"EARLY_PHASE1":1185,"PHASE1":1187,"PHASE2":1193,"PHASE3":1195,"PHASE4":1197,"NA":1199},{"trials":1186,"activeCount":62},[],{"trials":1188,"activeCount":62},[1189],{"nctId":1165,"briefTitle":1166,"status":85,"phases":1190,"primaryCompletion":1168,"completion":601,"start":947,"enrollment":1169,"conditions":1191,"interventions":1192},[51],[148,1171],[1158,1173,1174],{"trials":1194,"activeCount":62},[],{"trials":1196,"activeCount":62},[],{"trials":1198,"activeCount":62},[],{"trials":1200,"activeCount":62},[],{"intervention":1174,"totalTrials":104,"cells":1202},{"EARLY_PHASE1":1203,"PHASE1":1205,"PHASE2":1211,"PHASE3":1213,"PHASE4":1215,"NA":1217},{"trials":1204,"activeCount":62},[],{"trials":1206,"activeCount":62},[1207],{"nctId":1165,"briefTitle":1166,"status":85,"phases":1208,"primaryCompletion":1168,"completion":601,"start":947,"enrollment":1169,"conditions":1209,"interventions":1210},[51],[148,1171],[1158,1173,1174],{"trials":1212,"activeCount":62},[],{"trials":1214,"activeCount":62},[],{"trials":1216,"activeCount":62},[],{"trials":1218,"activeCount":62},[],{"intervention":1220,"totalTrials":104,"cells":1221},"CDFR0209",{"EARLY_PHASE1":1222,"PHASE1":1224,"PHASE2":1238,"PHASE3":1240,"PHASE4":1242,"NA":1244},{"trials":1223,"activeCount":62},[],{"trials":1225,"activeCount":62},[1226],{"nctId":1227,"briefTitle":1228,"status":85,"phases":1229,"primaryCompletion":1230,"completion":1231,"start":1232,"enrollment":726,"conditions":1233,"interventions":1236},"NCT02710994","Pharmacodynamics and Safety of CDFR0209",[51],"2014-08","2015-03","2014-05",[1234,1235],"Stomach Ulcer","Gastroesophageal Reflux",[1220,1237],"Losec",{"trials":1239,"activeCount":62},[],{"trials":1241,"activeCount":62},[],{"trials":1243,"activeCount":62},[],{"trials":1245,"activeCount":62},[],{"intervention":1237,"totalTrials":104,"cells":1247},{"EARLY_PHASE1":1248,"PHASE1":1250,"PHASE2":1256,"PHASE3":1258,"PHASE4":1260,"NA":1262},{"trials":1249,"activeCount":62},[],{"trials":1251,"activeCount":62},[1252],{"nctId":1227,"briefTitle":1228,"status":85,"phases":1253,"primaryCompletion":1230,"completion":1231,"start":1232,"enrollment":726,"conditions":1254,"interventions":1255},[51],[1234,1235],[1220,1237],{"trials":1257,"activeCount":62},[],{"trials":1259,"activeCount":62},[],{"trials":1261,"activeCount":62},[],{"trials":1263,"activeCount":62},[],{"intervention":1265,"totalTrials":104,"cells":1266},"Cloas",{"EARLY_PHASE1":1267,"PHASE1":1269,"PHASE2":1281,"PHASE3":1283,"PHASE4":1285,"NA":1287},{"trials":1268,"activeCount":62},[],{"trials":1270,"activeCount":62},[1271],{"nctId":1272,"briefTitle":1273,"status":197,"phases":1274,"primaryCompletion":1275,"completion":601,"start":1276,"enrollment":199,"conditions":1277,"interventions":1279},"NCT01388660","Pharmacokinetic Assessment of Simultaneous Administration of Clopidogrel and Aspirin",[51],"2014-09","2011-06",[1278],"Coronary Artery Disease",[1265,1280],"Plavix\u002FAstrix",{"trials":1282,"activeCount":62},[],{"trials":1284,"activeCount":62},[],{"trials":1286,"activeCount":62},[],{"trials":1288,"activeCount":62},[],{"intervention":1280,"totalTrials":104,"cells":1290},{"EARLY_PHASE1":1291,"PHASE1":1293,"PHASE2":1299,"PHASE3":1301,"PHASE4":1303,"NA":1305},{"trials":1292,"activeCount":62},[],{"trials":1294,"activeCount":62},[1295],{"nctId":1272,"briefTitle":1273,"status":197,"phases":1296,"primaryCompletion":1275,"completion":601,"start":1276,"enrollment":199,"conditions":1297,"interventions":1298},[51],[1278],[1265,1280],{"trials":1300,"activeCount":62},[],{"trials":1302,"activeCount":62},[],{"trials":1304,"activeCount":62},[],{"trials":1306,"activeCount":62},[],{"intervention":1308,"totalTrials":104,"cells":1309},"Simvastatin",{"EARLY_PHASE1":1310,"PHASE1":1312,"PHASE2":1325,"PHASE3":1327,"PHASE4":1329,"NA":1331},{"trials":1311,"activeCount":62},[],{"trials":1313,"activeCount":62},[1314],{"nctId":1315,"briefTitle":1316,"status":197,"phases":1317,"primaryCompletion":281,"start":1318,"enrollment":1319,"conditions":1320,"interventions":1322},"NCT02431013","Cilostazol-Simvastatin Drug Interaction Study",[51],"2015-04",20,[1321,1171],"Dyslipidemias",[1308,1323,1324],"Pravastatin","Cilostazol",{"trials":1326,"activeCount":62},[],{"trials":1328,"activeCount":62},[],{"trials":1330,"activeCount":62},[],{"trials":1332,"activeCount":62},[],{"intervention":1323,"totalTrials":104,"cells":1334},{"EARLY_PHASE1":1335,"PHASE1":1337,"PHASE2":1343,"PHASE3":1345,"PHASE4":1347,"NA":1349},{"trials":1336,"activeCount":62},[],{"trials":1338,"activeCount":62},[1339],{"nctId":1315,"briefTitle":1316,"status":197,"phases":1340,"primaryCompletion":281,"start":1318,"enrollment":1319,"conditions":1341,"interventions":1342},[51],[1321,1171],[1308,1323,1324],{"trials":1344,"activeCount":62},[],{"trials":1346,"activeCount":62},[],{"trials":1348,"activeCount":62},[],{"trials":1350,"activeCount":62},[],{"intervention":1324,"totalTrials":104,"cells":1352},{"EARLY_PHASE1":1353,"PHASE1":1355,"PHASE2":1361,"PHASE3":1363,"PHASE4":1365,"NA":1367},{"trials":1354,"activeCount":62},[],{"trials":1356,"activeCount":62},[1357],{"nctId":1315,"briefTitle":1316,"status":197,"phases":1358,"primaryCompletion":281,"start":1318,"enrollment":1319,"conditions":1359,"interventions":1360},[51],[1321,1171],[1308,1323,1324],{"trials":1362,"activeCount":62},[],{"trials":1364,"activeCount":62},[],{"trials":1366,"activeCount":62},[],{"trials":1368,"activeCount":62},[],{"intervention":237,"totalTrials":1370,"cells":1371},11,{"EARLY_PHASE1":1372,"PHASE1":1374,"PHASE2":1376,"PHASE3":1378,"PHASE4":1380,"NA":1438},{"trials":1373,"activeCount":62},[],{"trials":1375,"activeCount":62},[],{"trials":1377,"activeCount":62},[],{"trials":1379,"activeCount":62},[],{"trials":1381,"activeCount":62},[1382,1391,1395,1405,1413,1421,1425,1434],{"nctId":1383,"briefTitle":1384,"status":85,"phases":1385,"primaryCompletion":1386,"completion":1386,"start":1387,"enrollment":1388,"conditions":1389,"interventions":1390},"NCT03330782","Remifentanil for Preventing Propofol Injection Pain in Elderly Patients",[54],"2018-06-15","2017-11-16",52,[21],[237,237],{"nctId":390,"briefTitle":391,"status":85,"phases":1392,"primaryCompletion":393,"completion":393,"start":394,"enrollment":395,"conditions":1393,"interventions":1394},[54],[397,377,32],[377,399,400,401,402],{"nctId":1396,"briefTitle":1397,"status":85,"phases":1398,"primaryCompletion":1399,"completion":948,"start":1400,"enrollment":1401,"conditions":1402,"interventions":1403},"NCT02334046","Remifentanil for Smooth Emergence in Elderly Patients",[54],"2015-11","2015-02",47,[21],[237,237,1404],"Sevoflurane",{"nctId":1406,"briefTitle":1407,"status":85,"phases":1408,"primaryCompletion":1409,"completion":1409,"start":325,"enrollment":1410,"conditions":1411,"interventions":1412},"NCT01931683","Dosing Study of Remifentanil for Smooth Removal of the Laryngeal Mask Airway (LMA)",[54],"2014-02",27,[21],[400],{"nctId":1414,"briefTitle":1415,"status":85,"phases":1416,"primaryCompletion":493,"completion":493,"start":1231,"enrollment":1417,"conditions":1418,"interventions":1420},"NCT02382354","Remifentanil for the I-gel and Laryngeal Mask Airway Insertion",[54],41,[1419],"Supraglottic Airways for General Anesthesia",[400,402],{"nctId":860,"briefTitle":861,"status":85,"phases":1422,"primaryCompletion":492,"completion":492,"start":601,"enrollment":863,"conditions":1423,"interventions":1424},[54],[32],[237,847],{"nctId":1426,"briefTitle":1427,"status":85,"phases":1428,"primaryCompletion":1429,"completion":1429,"start":492,"enrollment":1038,"conditions":1430,"interventions":1432},"NCT02428283","Scalp Nerve Block on Emergence Agitation",[54],"2016-11",[1431],"Agitation",[1433,237,1404],"Ropivacaine",{"nctId":226,"briefTitle":227,"status":85,"phases":1435,"primaryCompletion":229,"completion":229,"start":230,"enrollment":231,"conditions":1436,"interventions":1437},[54],[233],[235,236,237],{"trials":1439,"activeCount":62},[1440,1451,1462],{"nctId":1441,"briefTitle":1442,"status":197,"phases":1443,"primaryCompletion":1444,"completion":1444,"start":1445,"enrollment":797,"conditions":1446,"interventions":1449},"NCT04455711","The Effect of Lidocaine on Smooth Emergence With Double Lumen Tube",[55],"2021-07-31","2020-07-01",[1447,1448],"Cough","Lidocaine",[1450,237],"Lidocaine Iv",{"nctId":1452,"briefTitle":1453,"status":85,"phases":1454,"primaryCompletion":1455,"completion":1456,"start":1457,"enrollment":1458,"conditions":1459,"interventions":1460},"NCT03622502","The Effect of Dexmedetomidine for Emergence Cough",[55],"2019-03-22","2019-03-27","2018-08-16",48,[1447],[753,237,1461],"Normal saline",{"nctId":1463,"briefTitle":1464,"status":85,"phases":1465,"primaryCompletion":1466,"completion":1466,"start":1429,"enrollment":1467,"conditions":1468,"interventions":1469},"NCT02973724","EC95 of Remifentanil for Preventing Cough",[55],"2017-06",40,[21],[237,1470],"Propofol anesthesia",{"intervention":1461,"totalTrials":16,"cells":1472},{"EARLY_PHASE1":1473,"PHASE1":1475,"PHASE2":1477,"PHASE3":1479,"PHASE4":1481,"NA":1495},{"trials":1474,"activeCount":62},[],{"trials":1476,"activeCount":62},[],{"trials":1478,"activeCount":62},[],{"trials":1480,"activeCount":62},[],{"trials":1482,"activeCount":62},[1483,1487],{"nctId":745,"briefTitle":746,"status":85,"phases":1484,"primaryCompletion":748,"completion":748,"start":749,"enrollment":750,"conditions":1485,"interventions":1486},[54],[752,753,754],[756,732,757],{"nctId":1488,"briefTitle":1489,"status":85,"phases":1490,"primaryCompletion":189,"completion":189,"start":839,"enrollment":1491,"conditions":1492,"interventions":1494},"NCT02284672","The Effect of Dexmedetomidine on Propofol Requirement for Insertion of Laryngeal Mask Airway",[54],39,[1493],"Precedex Effect to Propofol Requirement",[753,1461],{"trials":1496,"activeCount":62},[1497,1509,1518,1527,1531,1540],{"nctId":1498,"briefTitle":1499,"status":197,"phases":1500,"primaryCompletion":1501,"completion":1502,"start":1503,"enrollment":1504,"conditions":1505,"interventions":1507},"NCT02848287","Influence of 0.75% Ropivacaine Topicalization on Emergence Agitation in Children",[55],"2017-07","2017-08","2016-08",84,[1506],"Tonsillitis",[756,1508],"ropivacaine",{"nctId":1510,"briefTitle":1511,"status":85,"phases":1512,"primaryCompletion":1513,"completion":494,"start":1074,"enrollment":1514,"conditions":1515,"interventions":1516},"NCT01489683","Intubating Conditions During Propofol-remifentanil Anesthesia With Topical Lidocaine",[55],"2012-04",50,[21],[1517,756],"lidocaine",{"nctId":1519,"briefTitle":1520,"status":85,"phases":1521,"primaryCompletion":1522,"completion":1522,"start":466,"enrollment":1319,"conditions":1523,"interventions":1525},"NCT02826746","Effect of Intravenous Magnesium on Postoperative Sore Throat After Thyroidectomy",[55],"2019-03",[1524],"Thyroid Neoplasms",[1526,1461],"Magnesium Sulfate",{"nctId":1452,"briefTitle":1453,"status":85,"phases":1528,"primaryCompletion":1455,"completion":1456,"start":1457,"enrollment":1458,"conditions":1529,"interventions":1530},[55],[1447],[753,237,1461],{"nctId":1532,"briefTitle":1533,"status":85,"phases":1534,"primaryCompletion":1535,"completion":1535,"start":1536,"enrollment":199,"conditions":1537,"interventions":1539},"NCT02833038","Effect of Intravenous Magnesium During Robot Assisted Prostatectomy",[55],"2019-04","2016-04",[1538],"Prostatic Neoplasms",[1526,1461],{"nctId":1541,"briefTitle":1542,"status":85,"phases":1543,"primaryCompletion":1544,"completion":1544,"start":1545,"enrollment":469,"conditions":1546,"interventions":1547},"NCT04563260","Effect of Palonosetron on Remifentanil for Preventing Emergence Cough in Female",[55],"2021-03-19","2020-10-07",[26],[1461,1548],"Palonosetron Injection [Aloxi]",{"intervention":1550,"totalTrials":19,"cells":1551},"Propofol",{"EARLY_PHASE1":1552,"PHASE1":1554,"PHASE2":1556,"PHASE3":1558,"PHASE4":1560,"NA":1580},{"trials":1553,"activeCount":62},[],{"trials":1555,"activeCount":62},[],{"trials":1557,"activeCount":62},[],{"trials":1559,"activeCount":62},[],{"trials":1561,"activeCount":62},[1562,1566,1570],{"nctId":390,"briefTitle":391,"status":85,"phases":1563,"primaryCompletion":393,"completion":393,"start":394,"enrollment":395,"conditions":1564,"interventions":1565},[54],[397,377,32],[377,399,400,401,402],{"nctId":1414,"briefTitle":1415,"status":85,"phases":1567,"primaryCompletion":493,"completion":493,"start":1231,"enrollment":1417,"conditions":1568,"interventions":1569},[54],[1419],[400,402],{"nctId":1571,"briefTitle":1572,"status":85,"phases":1573,"primaryCompletion":1574,"completion":1574,"start":1575,"enrollment":1576,"conditions":1577,"interventions":1578},"NCT01852539","Dexmedetomidine for Laryngeal Mask Airway Insertion",[54],"2013-08","2013-07",22,[21],[1579,402],"dexmedetomidine",{"trials":1581,"activeCount":62},[1582,1591,1602,1612],{"nctId":1583,"briefTitle":1584,"status":85,"phases":1585,"primaryCompletion":1586,"completion":1586,"start":1587,"enrollment":1467,"conditions":1588,"interventions":1590},"NCT04514211","Heart Rate Variability and Postoperative Nausea Vomiting",[],"2021-12-31","2020-10-17",[1589],"Postoperative Nausea and Vomiting",[1550,1404],{"nctId":1592,"briefTitle":1593,"status":85,"phases":1594,"primaryCompletion":1595,"completion":1586,"start":1596,"enrollment":199,"conditions":1597,"interventions":1600},"NCT04142502","Comparison of the Effects of Dexmedetomidine and Propofol on the Cardiovascular Autonomic Nervous System During Spinal Anesthesia",[55],"2021-12-30","2020-01-20",[1598,1599],"Spinal Anesthesia","Autonomic Nervous System",[1550,1601],"Dexmedetomidin",{"nctId":1603,"briefTitle":1604,"status":197,"phases":1605,"primaryCompletion":1606,"completion":1607,"start":1608,"enrollment":1609,"conditions":1610,"interventions":1611},"NCT03927963","The Neuroprotection Effect of Dexmedetomidine",[55],"2020-09-30","2021-02-28","2019-05-01",70,[753],[753,1550],{"nctId":1613,"briefTitle":1614,"status":85,"phases":1615,"primaryCompletion":1616,"completion":1617,"start":1618,"enrollment":1619,"conditions":1620,"interventions":1622},"NCT05201300","Remimazolam and Propofol Anesthesia in Elderly Patients",[55],"2022-11-25","2023-01-18","2022-02-02",69,[1621],"Hemodynamics",[1623,1624,1550],"Remimazolam Besylate 6 mg\u002Fkg\u002Fhr","Remimazolam Besylate 12 mg\u002Fkg\u002Fhr",{"intervention":1404,"totalTrials":8,"cells":1626},{"EARLY_PHASE1":1627,"PHASE1":1629,"PHASE2":1631,"PHASE3":1633,"PHASE4":1635,"NA":1649},{"trials":1628,"activeCount":62},[],{"trials":1630,"activeCount":62},[],{"trials":1632,"activeCount":62},[],{"trials":1634,"activeCount":62},[],{"trials":1636,"activeCount":62},[1637,1641,1645],{"nctId":390,"briefTitle":391,"status":85,"phases":1638,"primaryCompletion":393,"completion":393,"start":394,"enrollment":395,"conditions":1639,"interventions":1640},[54],[397,377,32],[377,399,400,401,402],{"nctId":1396,"briefTitle":1397,"status":85,"phases":1642,"primaryCompletion":1399,"completion":948,"start":1400,"enrollment":1401,"conditions":1643,"interventions":1644},[54],[21],[237,237,1404],{"nctId":1426,"briefTitle":1427,"status":85,"phases":1646,"primaryCompletion":1429,"completion":1429,"start":492,"enrollment":1038,"conditions":1647,"interventions":1648},[54],[1431],[1433,237,1404],{"trials":1650,"activeCount":62},[1651,1655],{"nctId":1583,"briefTitle":1584,"status":85,"phases":1652,"primaryCompletion":1586,"completion":1586,"start":1587,"enrollment":1467,"conditions":1653,"interventions":1654},[],[1589],[1550,1404],{"nctId":1656,"briefTitle":1657,"status":197,"phases":1658,"primaryCompletion":1659,"completion":1660,"start":1661,"enrollment":12,"conditions":1662,"interventions":1664},"NCT05396690","Safety and Efficacy of Remimazolam in OPCAB Surgery",[55],"2023-05-30","2023-09-30","2022-06-15",[1663],"Coronary Artery Bypass Surgery",[1665,1404],"Remimazolam Injection [Byfavo]",{"intervention":753,"totalTrials":11,"cells":1667},{"EARLY_PHASE1":1668,"PHASE1":1670,"PHASE2":1672,"PHASE3":1674,"PHASE4":1676,"NA":1686},{"trials":1669,"activeCount":62},[],{"trials":1671,"activeCount":62},[],{"trials":1673,"activeCount":62},[],{"trials":1675,"activeCount":62},[],{"trials":1677,"activeCount":62},[1678,1682],{"nctId":1571,"briefTitle":1572,"status":85,"phases":1679,"primaryCompletion":1574,"completion":1574,"start":1575,"enrollment":1576,"conditions":1680,"interventions":1681},[54],[21],[1579,402],{"nctId":1488,"briefTitle":1489,"status":85,"phases":1683,"primaryCompletion":189,"completion":189,"start":839,"enrollment":1491,"conditions":1684,"interventions":1685},[54],[1493],[753,1461],{"trials":1687,"activeCount":62},[1688,1692],{"nctId":1452,"briefTitle":1453,"status":85,"phases":1689,"primaryCompletion":1455,"completion":1456,"start":1457,"enrollment":1458,"conditions":1690,"interventions":1691},[55],[1447],[753,237,1461],{"nctId":1603,"briefTitle":1604,"status":197,"phases":1693,"primaryCompletion":1606,"completion":1607,"start":1608,"enrollment":1609,"conditions":1694,"interventions":1695},[55],[753],[753,1550],{"intervention":1508,"totalTrials":172,"cells":1697},{"EARLY_PHASE1":1698,"PHASE1":1700,"PHASE2":1702,"PHASE3":1704,"PHASE4":1706,"NA":1712},{"trials":1699,"activeCount":62},[],{"trials":1701,"activeCount":62},[],{"trials":1703,"activeCount":62},[],{"trials":1705,"activeCount":62},[],{"trials":1707,"activeCount":62},[1708],{"nctId":1426,"briefTitle":1427,"status":85,"phases":1709,"primaryCompletion":1429,"completion":1429,"start":492,"enrollment":1038,"conditions":1710,"interventions":1711},[54],[1431],[1433,237,1404],{"trials":1713,"activeCount":62},[1714],{"nctId":1498,"briefTitle":1499,"status":197,"phases":1715,"primaryCompletion":1501,"completion":1502,"start":1503,"enrollment":1504,"conditions":1716,"interventions":1717},[55],[1506],[756,1508],{"intervention":1526,"totalTrials":172,"cells":1719},{"EARLY_PHASE1":1720,"PHASE1":1722,"PHASE2":1724,"PHASE3":1726,"PHASE4":1728,"NA":1730},{"trials":1721,"activeCount":62},[],{"trials":1723,"activeCount":62},[],{"trials":1725,"activeCount":62},[],{"trials":1727,"activeCount":62},[],{"trials":1729,"activeCount":62},[],{"trials":1731,"activeCount":62},[1732,1736],{"nctId":1519,"briefTitle":1520,"status":85,"phases":1733,"primaryCompletion":1522,"completion":1522,"start":466,"enrollment":1319,"conditions":1734,"interventions":1735},[55],[1524],[1526,1461],{"nctId":1532,"briefTitle":1533,"status":85,"phases":1737,"primaryCompletion":1535,"completion":1535,"start":1536,"enrollment":199,"conditions":1738,"interventions":1739},[55],[1538],[1526,1461],{"intervention":1741,"totalTrials":172,"cells":1742},"Sugammadex Injectable Product",{"EARLY_PHASE1":1743,"PHASE1":1745,"PHASE2":1747,"PHASE3":1749,"PHASE4":1751,"NA":1753},{"trials":1744,"activeCount":62},[],{"trials":1746,"activeCount":62},[],{"trials":1748,"activeCount":62},[],{"trials":1750,"activeCount":62},[],{"trials":1752,"activeCount":62},[],{"trials":1754,"activeCount":62},[1755,1766],{"nctId":1756,"briefTitle":1757,"status":85,"phases":1758,"primaryCompletion":1759,"completion":1760,"start":1761,"enrollment":1762,"conditions":1763,"interventions":1764},"NCT03583021","Sugammadex on Remifentanil Ce for Preventing Emergence Cough in Male",[55],"2018-10-31","2018-12-31","2018-06-25",42,[26],[1741,1765],"Neostigmine Injectable Product",{"nctId":1767,"briefTitle":1768,"status":85,"phases":1769,"primaryCompletion":1770,"completion":1770,"start":1771,"enrollment":1467,"conditions":1772,"interventions":1773},"NCT04407078","Sugammadex on Remifentanil Ce for Preventing Emergence Cough in Female",[55],"2021-01-06","2019-12-02",[26],[1741,1765],{"intervention":1765,"totalTrials":172,"cells":1775},{"EARLY_PHASE1":1776,"PHASE1":1778,"PHASE2":1780,"PHASE3":1782,"PHASE4":1784,"NA":1786},{"trials":1777,"activeCount":62},[],{"trials":1779,"activeCount":62},[],{"trials":1781,"activeCount":62},[],{"trials":1783,"activeCount":62},[],{"trials":1785,"activeCount":62},[],{"trials":1787,"activeCount":62},[1788,1792],{"nctId":1756,"briefTitle":1757,"status":85,"phases":1789,"primaryCompletion":1759,"completion":1760,"start":1761,"enrollment":1762,"conditions":1790,"interventions":1791},[55],[26],[1741,1765],{"nctId":1767,"briefTitle":1768,"status":85,"phases":1793,"primaryCompletion":1770,"completion":1770,"start":1771,"enrollment":1467,"conditions":1794,"interventions":1795},[55],[26],[1741,1765],{"intervention":1797,"totalTrials":172,"cells":1798},"Moderate neuromuscular block",{"EARLY_PHASE1":1799,"PHASE1":1801,"PHASE2":1803,"PHASE3":1805,"PHASE4":1807,"NA":1809},{"trials":1800,"activeCount":62},[],{"trials":1802,"activeCount":62},[],{"trials":1804,"activeCount":62},[],{"trials":1806,"activeCount":62},[],{"trials":1808,"activeCount":62},[],{"trials":1810,"activeCount":62},[1811,1822],{"nctId":1812,"briefTitle":1813,"status":85,"phases":1814,"primaryCompletion":1815,"completion":1815,"start":1816,"enrollment":1817,"conditions":1818,"interventions":1820},"NCT04022733","Remifentanil in Deep vs Moderate Neuromuscular Blocks During Surgical Pleth Index-guided Anesthesia for Laparoscopic Herniorrhaphy",[55],"2021-08-03","2019-10-30",134,[1819],"Hernia Abdominal Wall",[1797,1821],"Deep neuromuscular block",{"nctId":1823,"briefTitle":1824,"status":85,"phases":1825,"primaryCompletion":1826,"completion":1827,"start":1828,"enrollment":1829,"conditions":1830,"interventions":1832},"NCT03576118","Moderate vs Deep Neuromuscular Block on Biotrauma During Laparoscopy",[55],"2019-07-12","2019-09-19","2018-11-05",74,[1831],"Pneumoperitoneum",[1821,1797],{"intervention":1821,"totalTrials":172,"cells":1834},{"EARLY_PHASE1":1835,"PHASE1":1837,"PHASE2":1839,"PHASE3":1841,"PHASE4":1843,"NA":1845},{"trials":1836,"activeCount":62},[],{"trials":1838,"activeCount":62},[],{"trials":1840,"activeCount":62},[],{"trials":1842,"activeCount":62},[],{"trials":1844,"activeCount":62},[],{"trials":1846,"activeCount":62},[1847,1851],{"nctId":1812,"briefTitle":1813,"status":85,"phases":1848,"primaryCompletion":1815,"completion":1815,"start":1816,"enrollment":1817,"conditions":1849,"interventions":1850},[55],[1819],[1797,1821],{"nctId":1823,"briefTitle":1824,"status":85,"phases":1852,"primaryCompletion":1826,"completion":1827,"start":1828,"enrollment":1829,"conditions":1853,"interventions":1854},[55],[1831],[1821,1797],{"intervention":1450,"totalTrials":104,"cells":1856},{"EARLY_PHASE1":1857,"PHASE1":1859,"PHASE2":1861,"PHASE3":1863,"PHASE4":1865,"NA":1867},{"trials":1858,"activeCount":62},[],{"trials":1860,"activeCount":62},[],{"trials":1862,"activeCount":62},[],{"trials":1864,"activeCount":62},[],{"trials":1866,"activeCount":62},[],{"trials":1868,"activeCount":62},[1869],{"nctId":1441,"briefTitle":1442,"status":197,"phases":1870,"primaryCompletion":1444,"completion":1444,"start":1445,"enrollment":797,"conditions":1871,"interventions":1872},[55],[1447,1448],[1450,237],{"intervention":1874,"totalTrials":104,"cells":1875},"Macintosh Laryngoscopy",{"EARLY_PHASE1":1876,"PHASE1":1878,"PHASE2":1880,"PHASE3":1882,"PHASE4":1884,"NA":1886},{"trials":1877,"activeCount":62},[],{"trials":1879,"activeCount":62},[],{"trials":1881,"activeCount":62},[],{"trials":1883,"activeCount":62},[],{"trials":1885,"activeCount":62},[],{"trials":1887,"activeCount":62},[1888],{"nctId":1889,"briefTitle":1890,"status":85,"phases":1891,"primaryCompletion":1892,"completion":1892,"start":466,"enrollment":1504,"conditions":1893,"interventions":1895},"NCT02827123","A Comparison of McGrath MAC Videolaryngoscopy and Macintosh Laryngoscopy for Orotracheal Intubation in Children",[55],"2016-09",[1894],"Anesthesia, Endotracheal",[1874],{"intervention":1897,"totalTrials":104,"cells":1898},"Oral anticoagulant",{"EARLY_PHASE1":1899,"PHASE1":1901,"PHASE2":1903,"PHASE3":1905,"PHASE4":1907,"NA":1909},{"trials":1900,"activeCount":62},[],{"trials":1902,"activeCount":62},[],{"trials":1904,"activeCount":62},[],{"trials":1906,"activeCount":62},[],{"trials":1908,"activeCount":62},[],{"trials":1910,"activeCount":62},[1911],{"nctId":1912,"briefTitle":1913,"status":197,"phases":1914,"primaryCompletion":1915,"completion":1916,"start":1917,"enrollment":1918,"conditions":1919,"interventions":1923},"NCT05645913","Association of Obesity and Cardiovascular Outcomes in Atrial Fibrillation",[],"2024-10-31","2024-12-31","2022-01-01",56272,[1920,28,1921,1922],"Atrial Fibrillation","Prognosis","Anticoagulants",[1897],{"intervention":1517,"totalTrials":104,"cells":1925},{"EARLY_PHASE1":1926,"PHASE1":1928,"PHASE2":1930,"PHASE3":1932,"PHASE4":1934,"NA":1936},{"trials":1927,"activeCount":62},[],{"trials":1929,"activeCount":62},[],{"trials":1931,"activeCount":62},[],{"trials":1933,"activeCount":62},[],{"trials":1935,"activeCount":62},[],{"trials":1937,"activeCount":62},[1938],{"nctId":1510,"briefTitle":1511,"status":85,"phases":1939,"primaryCompletion":1513,"completion":494,"start":1074,"enrollment":1514,"conditions":1940,"interventions":1941},[55],[21],[1517,756],{"intervention":1943,"totalTrials":104,"cells":1944},"Remimazolam",{"EARLY_PHASE1":1945,"PHASE1":1947,"PHASE2":1949,"PHASE3":1951,"PHASE4":1953,"NA":1955},{"trials":1946,"activeCount":62},[],{"trials":1948,"activeCount":62},[],{"trials":1950,"activeCount":62},[],{"trials":1952,"activeCount":62},[],{"trials":1954,"activeCount":62},[],{"trials":1956,"activeCount":62},[1957],{"nctId":1958,"briefTitle":1959,"status":197,"phases":1960,"primaryCompletion":1961,"completion":1962,"start":1963,"enrollment":797,"conditions":1964,"interventions":1965},"NCT05434494","The Effect of Remifentanil on ED95 of Remimazolam for Loss of Consciousness in Adult Patients",[55],"2023-07-30","2023-08-31","2022-07-01",[1943],[1943,1966],"remifantanil",{"intervention":1966,"totalTrials":104,"cells":1968},{"EARLY_PHASE1":1969,"PHASE1":1971,"PHASE2":1973,"PHASE3":1975,"PHASE4":1977,"NA":1979},{"trials":1970,"activeCount":62},[],{"trials":1972,"activeCount":62},[],{"trials":1974,"activeCount":62},[],{"trials":1976,"activeCount":62},[],{"trials":1978,"activeCount":62},[],{"trials":1980,"activeCount":62},[1981],{"nctId":1958,"briefTitle":1959,"status":197,"phases":1982,"primaryCompletion":1961,"completion":1962,"start":1963,"enrollment":797,"conditions":1983,"interventions":1984},[55],[1943],[1943,1966],{"intervention":1601,"totalTrials":104,"cells":1986},{"EARLY_PHASE1":1987,"PHASE1":1989,"PHASE2":1991,"PHASE3":1993,"PHASE4":1995,"NA":1997},{"trials":1988,"activeCount":62},[],{"trials":1990,"activeCount":62},[],{"trials":1992,"activeCount":62},[],{"trials":1994,"activeCount":62},[],{"trials":1996,"activeCount":62},[],{"trials":1998,"activeCount":62},[1999],{"nctId":1592,"briefTitle":1593,"status":85,"phases":2000,"primaryCompletion":1595,"completion":1586,"start":1596,"enrollment":199,"conditions":2001,"interventions":2002},[55],[1598,1599],[1550,1601],{"intervention":2004,"totalTrials":104,"cells":2005},"Dipeptidyl peptidase-4 inhibitor",{"EARLY_PHASE1":2006,"PHASE1":2008,"PHASE2":2010,"PHASE3":2012,"PHASE4":2014,"NA":2016},{"trials":2007,"activeCount":62},[],{"trials":2009,"activeCount":62},[],{"trials":2011,"activeCount":62},[],{"trials":2013,"activeCount":62},[],{"trials":2015,"activeCount":62},[],{"trials":2017,"activeCount":62},[2018],{"nctId":2019,"briefTitle":2020,"status":197,"phases":2021,"primaryCompletion":2022,"completion":2022,"start":2023,"enrollment":2024,"conditions":2025,"interventions":2029},"NCT05817097","Effect of Dipeptidyl-4 Inhibitors in Reducing Stroke Severity, From HIRA Database",[],"2024-12-30","2023-08",22119,[2026,2027,2028],"Cerebral Infarction","Infarction, Brain","Dipeptidyl-Peptidase IV Inhibitors",[2004],{"intervention":2031,"totalTrials":104,"cells":2032},"tarivid ointment",{"EARLY_PHASE1":2033,"PHASE1":2035,"PHASE2":2037,"PHASE3":2039,"PHASE4":2041,"NA":2043},{"trials":2034,"activeCount":62},[],{"trials":2036,"activeCount":62},[],{"trials":2038,"activeCount":62},[],{"trials":2040,"activeCount":62},[],{"trials":2042,"activeCount":62},[],{"trials":2044,"activeCount":62},[2045],{"nctId":2046,"briefTitle":2047,"status":85,"phases":2048,"primaryCompletion":2049,"completion":2049,"start":2050,"enrollment":443,"conditions":2051,"interventions":2053},"NCT04426409","Nasal Ointment on Epistaxis of Nasotracheal Intubation in Children",[55],"2021-09-01","2020-07-08",[2052,24],"Epistaxis",[2031],{"intervention":2055,"totalTrials":104,"cells":2056},"Buprenorphine transdermal patch on knee joint",{"EARLY_PHASE1":2057,"PHASE1":2059,"PHASE2":2061,"PHASE3":2063,"PHASE4":2065,"NA":2067},{"trials":2058,"activeCount":62},[],{"trials":2060,"activeCount":62},[],{"trials":2062,"activeCount":62},[],{"trials":2064,"activeCount":62},[],{"trials":2066,"activeCount":62},[],{"trials":2068,"activeCount":62},[2069],{"nctId":2070,"briefTitle":2071,"status":197,"phases":2072,"primaryCompletion":2073,"completion":2074,"start":2075,"enrollment":2076,"conditions":2077,"interventions":2079},"NCT03947125","New Application of Buprenorphine Patch on Painful Knee Joint in Knee Osteoarthritis Patients",[],"2019-06-15","2019-07-30","2019-05-15",200,[2078],"Knee Osteoarthritis",[2055],{"intervention":2081,"totalTrials":104,"cells":2082},"Etomidate Injection 0.2 mg\u002Fkg",{"EARLY_PHASE1":2083,"PHASE1":2085,"PHASE2":2087,"PHASE3":2089,"PHASE4":2091,"NA":2093},{"trials":2084,"activeCount":62},[],{"trials":2086,"activeCount":62},[],{"trials":2088,"activeCount":62},[],{"trials":2090,"activeCount":62},[],{"trials":2092,"activeCount":62},[],{"trials":2094,"activeCount":62},[2095],{"nctId":2096,"briefTitle":2097,"status":2098,"phases":2099,"primaryCompletion":2100,"completion":1595,"start":2101,"enrollment":2102,"conditions":2103,"interventions":2105},"NCT04120870","Comparison of Ketamine and Etomidate During Rapid Sequence Intubation in Trauma Patients","TERMINATED",[55],"2021-11-30","2019-10-01",10,[30,2104],"Shock, Traumatic",[2081,2106],"Ketamine injection 2 mg\u002Fkg",{"intervention":2106,"totalTrials":104,"cells":2108},{"EARLY_PHASE1":2109,"PHASE1":2111,"PHASE2":2113,"PHASE3":2115,"PHASE4":2117,"NA":2119},{"trials":2110,"activeCount":62},[],{"trials":2112,"activeCount":62},[],{"trials":2114,"activeCount":62},[],{"trials":2116,"activeCount":62},[],{"trials":2118,"activeCount":62},[],{"trials":2120,"activeCount":62},[2121],{"nctId":2096,"briefTitle":2097,"status":2098,"phases":2122,"primaryCompletion":2100,"completion":1595,"start":2101,"enrollment":2102,"conditions":2123,"interventions":2124},[55],[30,2104],[2081,2106],{"intervention":1470,"totalTrials":104,"cells":2126},{"EARLY_PHASE1":2127,"PHASE1":2129,"PHASE2":2131,"PHASE3":2133,"PHASE4":2135,"NA":2137},{"trials":2128,"activeCount":62},[],{"trials":2130,"activeCount":62},[],{"trials":2132,"activeCount":62},[],{"trials":2134,"activeCount":62},[],{"trials":2136,"activeCount":62},[],{"trials":2138,"activeCount":62},[2139],{"nctId":1463,"briefTitle":1464,"status":85,"phases":2140,"primaryCompletion":1466,"completion":1466,"start":1429,"enrollment":1467,"conditions":2141,"interventions":2142},[55],[21],[237,1470],{"intervention":1548,"totalTrials":104,"cells":2144},{"EARLY_PHASE1":2145,"PHASE1":2147,"PHASE2":2149,"PHASE3":2151,"PHASE4":2153,"NA":2155},{"trials":2146,"activeCount":62},[],{"trials":2148,"activeCount":62},[],{"trials":2150,"activeCount":62},[],{"trials":2152,"activeCount":62},[],{"trials":2154,"activeCount":62},[],{"trials":2156,"activeCount":62},[2157],{"nctId":1541,"briefTitle":1542,"status":85,"phases":2158,"primaryCompletion":1544,"completion":1544,"start":1545,"enrollment":469,"conditions":2159,"interventions":2160},[55],[26],[1461,1548],{"intervention":2162,"totalTrials":104,"cells":2163},"Ticagrelor 180mg",{"EARLY_PHASE1":2164,"PHASE1":2166,"PHASE2":2168,"PHASE3":2170,"PHASE4":2172,"NA":2174},{"trials":2165,"activeCount":62},[],{"trials":2167,"activeCount":62},[],{"trials":2169,"activeCount":62},[],{"trials":2171,"activeCount":62},[],{"trials":2173,"activeCount":62},[],{"trials":2175,"activeCount":62},[2176],{"nctId":2177,"briefTitle":2178,"status":85,"phases":2179,"primaryCompletion":2180,"completion":2181,"start":2182,"enrollment":2183,"conditions":2184,"interventions":2188},"NCT04431349","Comparison of CABG Related Bleeding Complications in Patients Treated With Ticagrelor or Clopidogrel",[],"2019-09-30","2020-05-06","2016-01-01",1097,[2185,2186,2187],"Blood Loss, Surgical","Ticagrelor","Clopidogrel",[2162,2189],"Clopidogrel 75mg",{"intervention":2189,"totalTrials":104,"cells":2191},{"EARLY_PHASE1":2192,"PHASE1":2194,"PHASE2":2196,"PHASE3":2198,"PHASE4":2200,"NA":2202},{"trials":2193,"activeCount":62},[],{"trials":2195,"activeCount":62},[],{"trials":2197,"activeCount":62},[],{"trials":2199,"activeCount":62},[],{"trials":2201,"activeCount":62},[],{"trials":2203,"activeCount":62},[2204],{"nctId":2177,"briefTitle":2178,"status":85,"phases":2205,"primaryCompletion":2180,"completion":2181,"start":2182,"enrollment":2183,"conditions":2206,"interventions":2207},[],[2185,2186,2187],[2162,2189],{"intervention":2209,"totalTrials":104,"cells":2210},"Combination cream",{"EARLY_PHASE1":2211,"PHASE1":2213,"PHASE2":2215,"PHASE3":2217,"PHASE4":2219,"NA":2221},{"trials":2212,"activeCount":62},[],{"trials":2214,"activeCount":62},[],{"trials":2216,"activeCount":62},[],{"trials":2218,"activeCount":62},[],{"trials":2220,"activeCount":62},[],{"trials":2222,"activeCount":62},[2223],{"nctId":2224,"briefTitle":2225,"status":85,"phases":2226,"primaryCompletion":2227,"completion":2228,"start":2229,"enrollment":2230,"conditions":2231,"interventions":2234},"NCT05710068","Effects of RF Microneedle on Photoaging Skin",[55],"2022-08-01","2022-09-01","2021-12-01",15,[2232,2233],"Pigmentation","Pigmentation Disorder",[2209],{"intervention":2236,"totalTrials":104,"cells":2237},"Desflurane Inhalation Solution",{"EARLY_PHASE1":2238,"PHASE1":2240,"PHASE2":2242,"PHASE3":2244,"PHASE4":2246,"NA":2248},{"trials":2239,"activeCount":62},[],{"trials":2241,"activeCount":62},[],{"trials":2243,"activeCount":62},[],{"trials":2245,"activeCount":62},[],{"trials":2247,"activeCount":62},[],{"trials":2249,"activeCount":62},[2250],{"nctId":2251,"briefTitle":2252,"status":197,"phases":2253,"primaryCompletion":2254,"completion":2254,"start":2255,"enrollment":2256,"conditions":2257,"interventions":2259},"NCT06123624","Desflurane and Sevoflurane on Remifentanil Requirement",[55],"2024-08-30","2023-11-27",78,[2258],"Spinal Diseases",[2236,2260],"Sevoflurane Inhalation Solution",{"intervention":2260,"totalTrials":104,"cells":2262},{"EARLY_PHASE1":2263,"PHASE1":2265,"PHASE2":2267,"PHASE3":2269,"PHASE4":2271,"NA":2273},{"trials":2264,"activeCount":62},[],{"trials":2266,"activeCount":62},[],{"trials":2268,"activeCount":62},[],{"trials":2270,"activeCount":62},[],{"trials":2272,"activeCount":62},[],{"trials":2274,"activeCount":62},[2275],{"nctId":2251,"briefTitle":2252,"status":197,"phases":2276,"primaryCompletion":2254,"completion":2254,"start":2255,"enrollment":2256,"conditions":2277,"interventions":2278},[55],[2258],[2236,2260],{"intervention":2280,"totalTrials":104,"cells":2281},"Corticosteroid",{"EARLY_PHASE1":2282,"PHASE1":2284,"PHASE2":2286,"PHASE3":2288,"PHASE4":2290,"NA":2292},{"trials":2283,"activeCount":62},[],{"trials":2285,"activeCount":62},[],{"trials":2287,"activeCount":62},[],{"trials":2289,"activeCount":62},[],{"trials":2291,"activeCount":62},[],{"trials":2293,"activeCount":62},[2294],{"nctId":2295,"briefTitle":2296,"status":85,"phases":2297,"primaryCompletion":2022,"completion":2298,"start":2299,"enrollment":2300,"conditions":2301,"interventions":2305},"NCT06279078","Long-term Effect of Steroid on Metabolic Diseases in Asthmatics",[],"2025-06-30","2023-12-30",19968,[992,2302,2303,2304],"Osteoporosis, Osteopenia","Osteoporosis Risk","Osteoporotic Fractures",[2280],{"intervention":1665,"totalTrials":104,"cells":2307},{"EARLY_PHASE1":2308,"PHASE1":2310,"PHASE2":2312,"PHASE3":2314,"PHASE4":2316,"NA":2318},{"trials":2309,"activeCount":62},[],{"trials":2311,"activeCount":62},[],{"trials":2313,"activeCount":62},[],{"trials":2315,"activeCount":62},[],{"trials":2317,"activeCount":62},[],{"trials":2319,"activeCount":62},[2320],{"nctId":1656,"briefTitle":1657,"status":197,"phases":2321,"primaryCompletion":1659,"completion":1660,"start":1661,"enrollment":12,"conditions":2322,"interventions":2323},[55],[1663],[1665,1404],{"intervention":2325,"totalTrials":104,"cells":2326},"Lidocaine patch and hypafix",{"EARLY_PHASE1":2327,"PHASE1":2329,"PHASE2":2331,"PHASE3":2333,"PHASE4":2335,"NA":2337},{"trials":2328,"activeCount":62},[],{"trials":2330,"activeCount":62},[],{"trials":2332,"activeCount":62},[],{"trials":2334,"activeCount":62},[],{"trials":2336,"activeCount":62},[],{"trials":2338,"activeCount":62},[2339],{"nctId":2340,"briefTitle":2341,"status":85,"phases":2342,"primaryCompletion":2343,"completion":2343,"start":2344,"enrollment":2345,"conditions":2346,"interventions":2347},"NCT02827136","Effect of Lidocaine Patch for Shoulder Pain in Laparoscopic Cholecystectomy",[55],"2017-09-27","2017-02-08",63,[26],[2325,2348],"hypafix",{"intervention":2348,"totalTrials":104,"cells":2350},{"EARLY_PHASE1":2351,"PHASE1":2353,"PHASE2":2355,"PHASE3":2357,"PHASE4":2359,"NA":2361},{"trials":2352,"activeCount":62},[],{"trials":2354,"activeCount":62},[],{"trials":2356,"activeCount":62},[],{"trials":2358,"activeCount":62},[],{"trials":2360,"activeCount":62},[],{"trials":2362,"activeCount":62},[2363],{"nctId":2340,"briefTitle":2341,"status":85,"phases":2364,"primaryCompletion":2343,"completion":2343,"start":2344,"enrollment":2345,"conditions":2365,"interventions":2366},[55],[26],[2325,2348],{"intervention":1623,"totalTrials":104,"cells":2368},{"EARLY_PHASE1":2369,"PHASE1":2371,"PHASE2":2373,"PHASE3":2375,"PHASE4":2377,"NA":2379},{"trials":2370,"activeCount":62},[],{"trials":2372,"activeCount":62},[],{"trials":2374,"activeCount":62},[],{"trials":2376,"activeCount":62},[],{"trials":2378,"activeCount":62},[],{"trials":2380,"activeCount":62},[2381],{"nctId":1613,"briefTitle":1614,"status":85,"phases":2382,"primaryCompletion":1616,"completion":1617,"start":1618,"enrollment":1619,"conditions":2383,"interventions":2384},[55],[1621],[1623,1624,1550],{"intervention":1624,"totalTrials":104,"cells":2386},{"EARLY_PHASE1":2387,"PHASE1":2389,"PHASE2":2391,"PHASE3":2393,"PHASE4":2395,"NA":2397},{"trials":2388,"activeCount":62},[],{"trials":2390,"activeCount":62},[],{"trials":2392,"activeCount":62},[],{"trials":2394,"activeCount":62},[],{"trials":2396,"activeCount":62},[],{"trials":2398,"activeCount":62},[2399],{"nctId":1613,"briefTitle":1614,"status":85,"phases":2400,"primaryCompletion":1616,"completion":1617,"start":1618,"enrollment":1619,"conditions":2401,"interventions":2402},[55],[1621],[1623,1624,1550],{"intervention":2404,"totalTrials":104,"cells":2405},"denogan and rectus sheath block",{"EARLY_PHASE1":2406,"PHASE1":2408,"PHASE2":2410,"PHASE3":2412,"PHASE4":2414,"NA":2416},{"trials":2407,"activeCount":62},[],{"trials":2409,"activeCount":62},[],{"trials":2411,"activeCount":62},[],{"trials":2413,"activeCount":62},[],{"trials":2415,"activeCount":62},[],{"trials":2417,"activeCount":62},[2418],{"nctId":2419,"briefTitle":2420,"status":2421,"phases":2422,"primaryCompletion":2423,"completion":2423,"start":2423,"enrollment":62,"conditions":2424,"interventions":2425},"NCT02827097","The Effect of Rectus Sheath Block on the Postoperative Analgesia in the Patients Undergoing Robotic Single Port Cholecystectomy","WITHDRAWN",[55],"2016-10",[26],[2404,2426],"denogan",{"intervention":2426,"totalTrials":104,"cells":2428},{"EARLY_PHASE1":2429,"PHASE1":2431,"PHASE2":2433,"PHASE3":2435,"PHASE4":2437,"NA":2439},{"trials":2430,"activeCount":62},[],{"trials":2432,"activeCount":62},[],{"trials":2434,"activeCount":62},[],{"trials":2436,"activeCount":62},[],{"trials":2438,"activeCount":62},[],{"trials":2440,"activeCount":62},[2441],{"nctId":2419,"briefTitle":2420,"status":2421,"phases":2442,"primaryCompletion":2423,"completion":2423,"start":2423,"enrollment":62,"conditions":2443,"interventions":2444},[55],[26],[2404,2426],{"intervention":2446,"totalTrials":104,"cells":2447},"Ulinastatin",{"EARLY_PHASE1":2448,"PHASE1":2450,"PHASE2":2452,"PHASE3":2454,"PHASE4":2456,"NA":2458},{"trials":2449,"activeCount":62},[],{"trials":2451,"activeCount":62},[],{"trials":2453,"activeCount":62},[],{"trials":2455,"activeCount":62},[],{"trials":2457,"activeCount":62},[],{"trials":2459,"activeCount":62},[2460],{"nctId":2461,"briefTitle":2462,"status":197,"phases":2463,"primaryCompletion":2464,"completion":2465,"start":2466,"enrollment":2467,"conditions":2468,"interventions":2470},"NCT04473144","The Effect of Ulistin on Acute Renal Injury in Patients Undergoing OPCAB (Off Pump Coronary Artery Bypass): a Propensity Score Matched Study",[55],"2021-07-01","2021-08-31","2020-08-01",500,[2469],"Acute Kidney Injury",[2446],{"intervention":103,"totalTrials":104,"cells":2472},{"EARLY_PHASE1":2473,"PHASE1":2475,"PHASE2":2477,"PHASE3":2479,"PHASE4":2481,"NA":2483},{"trials":2474,"activeCount":62},[],{"trials":2476,"activeCount":62},[],{"trials":2478,"activeCount":62},[],{"trials":2480,"activeCount":62},[],{"trials":2482,"activeCount":62},[],{"trials":2484,"activeCount":62},[2485],{"nctId":95,"briefTitle":96,"status":85,"phases":2486,"primaryCompletion":98,"completion":98,"start":99,"enrollment":100,"conditions":2487,"interventions":2488},[55],[15],[103,58],{"intervention":2490,"totalTrials":104,"cells":2491},"Topical tacrolimus 0.1% ointment",{"EARLY_PHASE1":2492,"PHASE1":2494,"PHASE2":2496,"PHASE3":2498,"PHASE4":2500,"NA":2502},{"trials":2493,"activeCount":62},[],{"trials":2495,"activeCount":62},[],{"trials":2497,"activeCount":62},[],{"trials":2499,"activeCount":62},[],{"trials":2501,"activeCount":62},[],{"trials":2503,"activeCount":62},[2504],{"nctId":2505,"briefTitle":2506,"status":85,"phases":2507,"primaryCompletion":2508,"completion":2508,"start":2509,"enrollment":2510,"conditions":2511,"interventions":2514},"NCT03047733","Comparison of Cyclic On-off and Continuous Excimer Laser Treatment for Vitiligo",[55],"2016-12-31","2015-07-21",12,[2512,2513],"Dermatologic Disease","Vitiligo",[2490]]